About this trial
Older adults with type 2 diabetes are at higher risk for severe hypoglycemia and its related complications (including hospitalization and death) when taking insulin. This study proposes to evaluate, in a randomized clinical trial, a strategy of safe insulin prescribing based on an educational program that leverages continuous glucose monitoring to support older adults at high risk for hypoglycemia. If the aims of this project are achieved, this novel care strategy could be widely applied to reduce severe hypoglycemia episodes in older, high-risk adults with type 2 diabetes.
Eligibility criteria
Qualifiers
Age 75 years and older
Diagnosis of Type 2 Diabetes
Current treatment with insulin
Increased hypoglycemia risk (prior year hypoglycemia by self-report or utilization)
Disqualifiers
On renal dialysis
Dementia
Pacemaker or Automatic Implantable Cardioverter Defibrillator
Using insulin pump
Trial design
Treatments tested in this trial
- SAGE Group Sessions
- Usual Care
Treatment groups
Sponsors and collaborators
Kaiser Permanente
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator